Bio-Reference Laboratories, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bio-Reference Laboratories, Inc. - overview

Established

1981

Location

-, NJ, US

Primary Industry

Healthcare IT

About

Bio-Reference Laboratories, Inc. is a prominent clinical laboratory offering specialized diagnostic testing services, focusing on oncology, urology, and women’s health, enhancing healthcare decision-making for providers nationwide. Founded in 1981, Bio-Reference Laboratories, Inc. specializes in laboratory diagnostic services.


The company operates from its headquarters in Elmwood Park, New Jersey, and has expanded its services across the United States, particularly outside of New York and New Jersey. The CEO is Jon Cohen. BioReference® Health offers a comprehensive range of laboratory diagnostic services primarily focused on oncology, urology, and women’s health. Their core product offerings include specialized tests such as the 4Kscore® Test, which assesses prostate cancer risk, and various oncology diagnostics that provide critical information to healthcare providers for patient management.


The company emphasizes a streamlined healthcare experience, utilizing a secure, cloud-based provider portal for 24/7 access to test orders and results. BioReference® serves a diverse client base that includes healthcare providers, hospitals, and clinics across the United States, particularly in markets outside of New York and New Jersey, where they continue to operate comprehensive services. Their commitment to scientific excellence positions them as a trusted partner for healthcare professionals seeking reliable and innovative laboratory solutions. BioReference® Health generates revenue through a transactional structure that encompasses various diagnostic services provided to healthcare providers and institutions.


The company operates primarily on a B2B model, supplying diagnostic tests that are billed directly to healthcare providers or through insurance reimbursement processes. Notably, their flagship products, such as the 4Kscore® Test, are integral to their revenue stream, as they cater to the specialized needs of urology and oncology diagnostics. This transactional relationship enables BioReference® to maintain a steady flow of revenue as healthcare providers order tests, with billing often simplified through partnerships with major health plans across the United States. The company's focus on laboratory services and innovative diagnostic solutions contributes to its financial stability within the competitive healthcare landscape.


Primary Industry

Healthcare IT

Sub Industries

Healthcare IT

Website

www.bioreference.com

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.